IPO Timeline
Broker Results (T-2)
2021-10-15
Some brokers release in afternoon
Grey Market (T-1)
2021-10-18
Afternoon
HKEX Allotment (T-1)
2021-10-18
Evening
Registrar Allotment (T-1)
2021-10-18
Evening
Listing Day (T)
2021-10-19
First day of trading
Company Overview
| Stock Name | 微泰醫療器械(杭州)股份有限公司 - B - H股 |
|---|---|
| Stock Code | 02235 |
| Company Full Name | 微泰醫療器械(杭州)股份有限公司 - B - H股 |
| Industry | 醫療保健 |
| Principal Activities | 主要從事糖尿病管理醫療器械及耗材的研發、生產及商業化。 |
| Listing Date | 2021-10-19 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市余杭區倉前街道留澤街108號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.microtechmd.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 30.50 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 61.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 193,766,500 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 30.5 |
|---|---|
| First Day Open | HK$ 31.0 |
| First Day Change | -73.97% |
| First Day Volume | 6776600.0 |
| First Day Turnover | 207865000.0 |
Use of Proceeds
| Use of Proceeds | 1、31%（或約562.7百萬港元）分配予我們的核心產品； 2、35%（或約635.3百萬港元）分配予我們的持續血糖監測系統； 3、11%（或約199.7百萬港元）將分配至我們第二代貼敷式胰島素泵系統的臨床 前研究、臨床試驗、注冊、生產及商業化； 4、8%（或約145.2百萬港元）將分配至我們其他產品及在研產品的臨床前研 究、臨床試驗、注冊、生產及商業化； 5、5%（或約90.8百萬港元）將用于為建立我們基于云端大數據的糖尿病管理平 臺提供資金； 6、10%（或約181.5百萬港元）將分配用于營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (3)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
中信里昂证券有限公司 CE AAB893
Joint Lead Managers (3)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
中信里昂证券有限公司 CE AAB893
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Boyu Capital Opportunities Master Fund | 77,832,950 HKD | — | 4.00% | — | 6 months | 2022-04-19 |
| 2 | Hudson Bay Master Fund LTD | 97,288,900 HKD | — | 5.00% | — | 6 months | 2022-04-19 |
| 3 | Invesco Advisers, Inc. | 272,413,800 HKD | — | 14.10% | — | 6 months | 2022-04-19 |
| 4 | Lake Bleu Prime Healthcare Master Fund Limited | 77,832,950 HKD | — | 4.00% | — | 6 months | 2022-04-19 |
| 5 | LAV Star Limited | 97,288,900 HKD | — | 5.00% | — | 6 months | 2022-04-19 |
| 6 | Octagon Investments Master Fund LP | 77,832,950 HKD | — | 4.00% | — | 6 months | 2022-04-19 |
| 7 | OrbiMed Genesis Master Fund,L.P. | 62,265,750 HKD | — | 3.20% | — | 6 months | 2022-04-19 |
| 8 | Sage Partners Master Fund | 62,265,750 HKD | — | 3.20% | — | 6 months | 2022-04-19 |
| 9 | Springhill Master Fund Limited | 97,288,900 HKD | — | 5.00% | — | 6 months | 2022-04-19 |
| 10 | Tencent Mobility Limited | 77,832,950 HKD | — | 4.00% | — | 6 months | 2022-04-19 |
| 11 | UBS Asset Management (Singapore) Ltd. | 194,580,850 HKD | — | 10.00% | — | 6 months | 2022-04-19 |
Directors & Management
| Chairman | 鄭攀 |
|---|---|
| Company Secretary | 朱璧敏;施永輝 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 鄭攀(28.9%);Qiming Corporate GP V, Ltd(8.04%);浙江九仁資本管理有限公司(6.58%);施毅(6.02%);朱勇(5.52%);陳飛(5.12%) |
|---|
IPO Timeline
